Aarey Drugs & Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

25.38

25.38

23.38

23.38

23.38

Share application money

2.32

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

89.71

88.25

75.48

68.96

63.17

Loan funds

Secured loans

37.72

14.16

18.02

17.89

16.16

Unsecured loans

-

-

-

-

-

Total

155.13

127.80

116.88

110.23

102.71

Uses of funds

Fixed assets

Gross block

13.94

32.13

29.93

27.05

26.13

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

17.66

15.67

14.75

13.86

Net block

13.94

14.47

14.26

12.30

12.27

Capital work-in-progress

-

-

-

-

-

Investments

0.40

0.40

0.40

0.44

0.44

Net current assets

Current assets, loans & advances

276.99

230.30

218.38

181.34

133.00

Less : current liabilities & provisions

136.20

117.37

116.16

83.85

43.01

Total net current assets

140.79

112.93

102.22

97.49

89.99

Miscellaneous expenses not written

-

-

-

-

-

Total

155.13

127.80

116.88

110.23

102.71

Notes:

Book value of unquoted investments

0.40

0.40

0.40

0.44

0.44

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

253.85

253.85

233.85

233.85

233.85